42 U.S. Code § 285b–8 - Congenital heart disease
prev | next
(a) In general
The Director of the Institute may expand, intensify, and coordinate research and related activities of the Institute with respect to congenital heart disease, which may include congenital heart disease research with respect to—
(2) long-term outcomes in individuals with congenital heart disease, including infants, children, teenagers, adults, and elderly individuals;
(4) studies using longitudinal data and retrospective analysis to identify effective treatments and outcomes for individuals with congenital heart disease; and
(b) Coordination of research activities
The Director of the Institute may coordinate research efforts related to congenital heart disease among multiple research institutions and may develop research networks.
Source(July 1, 1944, ch. 373, title IV, § 425, as added Pub. L. 111–148, title X, § 10411(b)(2),Mar. 23, 2010, 124 Stat. 989.)
A prior section 285b–8, act July 1, 1944, ch. 373, title IV, § 425, as added Pub. L. 103–43, title V, § 504,June 10, 1993, 107 Stat. 160, authorized appropriations to carry out this subpart, prior to repeal by Pub. L. 109–482, title I, §§ 103(b)(20), 109,Jan. 15, 2007, 120 Stat. 3688, 3697, applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years.
LII has no control over and does not endorse any external Internet site that contains links to or references LII.